Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference
LX9211 Late-Stage Development Underway, with Potential to Be First New Non-Opioid Drug for Diabetic Peripheral Neuropathic Pain in Over Two Decades- THE…
United States Lexicon Pharmaceuticals Inc Stage Development Underway Diabetic Peripheral Neuropathic Pain Lover Two Reaking News
Source: biztoc.com